CA
NZ
UK
AU
IND
US
Director Carolyn Downey filed a Form 4 with the SEC on August 25, 2026, reporting the conversion of vested phantom stock units into ARMOUR Residential REIT, Inc. common shares on August 21, 2026.
A Form 4 filed on August 25, 2026 disclosed that Anthony L. Grande, Executive Vice President and Chief Development Officer of CoreCivic, Inc., sold 7,436 shares of common stock on August 24, 2026.
Timothy Holme, Chief Technology Officer of QuantumScape Corp (NASDAQ:QS), filed a Form 4 on August 25, 2026, disclosing the conversion and sale of 12,723 shares of Class A Common Stock on August 21, 2026, executed through The Holme 2020 Irrevocable Trust.
Maria Cristina Mendez Echevarria, Executive Vice President and CFO of Otis Worldwide Corp, filed a Form 4 on August 25, 2026, disclosing transactions in common stock and restricted stock units dated August 23, 2026.
Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc, filed a statement of changes in beneficial ownership with the SEC on August 25, 2026, reporting the acquisition of deferred stock units dated August 21, 2026.
Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc, filed a statement of changes in beneficial ownership on August 25, 2026, reporting an acquisition of deferred stock units dated August 21, 2026.
Robert M. VanHimbergen, Executive Vice President and CFO of Elanco Animal Health Incorporated, filed a statement of changes in beneficial ownership on August 25, 2026, reporting the acquisition of deferred stock units on August 21, 2026.
Ronald A. Brack, Executive Vice President, Chief Accounting Officer and Controller of GEO Group Inc, filed a statement of changes in beneficial ownership on August 25, 2026, reporting a sale of common stock and disclosing a prior share transfer tied to a domestic relations …
August J. Troendle, President and CEO of Medpace Holdings, Inc., filed a Form 4 on August 25, 2026, disclosing the sale of common stock on August 21 and August 24, 2026, traded on NASDAQ:MEDP.
A Form 4 filed on August 25, 2026 reports that David Nicholas Gee, Chief Marketing Officer of Cellebrite DI Ltd. (NASDAQ:CLBT), sold 4,323 ordinary shares on August 24, 2026 pursuant to a pre-established Rule 10b5-1 trading plan.
Please wait processing your request...